RxDoctor Payments DataLook up a doctor →

Isaac Tawfik, MD

Interventional Cardiology · Eatontown, NJNPI 1073612990

Payments from drug & device makers

$22,672in general payments, 2019–2025

Across 582 payments — averaging $38.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$9K
  • Philips North America LLC$2K
  • Abbott$2K
  • Irhythm Technologies, Inc.$808
  • Johnson & Johnson$793
  • AstraZeneca$681
  • plus $8K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis69$8,778
Philips North America LLC5$1,689
Abbott18$1,506
Irhythm Technologies, Inc.35$808
Johnson & Johnson55$793
AstraZeneca29$681
Amgen43$663
Actelion Pharmaceuticals US, Inc.34$648
Boston Scientific10$579
Merck37$571
Medtronic(2 entities)18$544
Boehringer Ingelheim28$531
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)13$478
E.r. Squibb & Sons, L.L.C.29$457
Bard Peripheral Vascular, Inc.9$410
Pfizer22$327
Cardiovascular Systems Inc.5$305
Abiomed5$303
Cvrx, Inc.8$232
Alnylam Pharmaceuticals Inc.5$190
Bayer5$184
Acist Medical Systems, Inc.4$170
Novo Nordisk4$160
Amarin Pharma, Inc.10$136
Penumbra, Inc.1$110
Esperion Therapeutics, Inc.7$103
Arbor Pharmaceuticals, Inc.7$96
Regeneron Healthcare Solutions, Inc.6$91
Silk Road Medical, Inc.2$78
Heartflow, Inc.3$75
Kestra Medical Technology Services, Inc.1$73
United Therapeutics Corporation4$72
Kiniksa Pharmaceuticals, Ltd.5$71
Imperative Care, Inc3$70
W. L. Gore & Associates, Inc.5$66
Scpharmaceuticals Inc.3$51
Sanofi-aventis U.S. LLC3$42
Stryker1$40
Angiodynamics, Inc.2$39
Akcea Therapeutics, Inc.3$37
Misonix Inc2$34
Daiichi Sankyo Inc.2$32
Bardy Diagnostics, Inc.2$30
Lundbeck LLC2$27
Sanofi2$27
Cashflow Solutions, LLC2$26
Kowa Pharmaceuticals America, Inc.2$26
Chiesi USA, Inc.1$25
Sensible Medical Innovations Inc1$23
Agepha Pharma FZ LLC1$20
Baxter Healthcare1$18
Biogen1$17
Kiniksa Pharmaceuticals International, PLC1$17
Shockwave Medical, Inc1$17
Tactile Systems Technology Inc1$16
Impulse Dynamics (USA) Inc.1$15
Cardinal Health 200 LLC1$15
Gilead1$14
Portola Pharmaceuticals, LLC1$14

How this compares

$22,672 in reported general payments places this provider in the 70th percentile of 166 interventional cardiology providers in New Jersey.

See all interventional cardiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$927,259
Medicare patients
1,902
Services billed
6,624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Eatontown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →